Generate a differential diagnosis and prioritize based on clinical features that suggest a specific aetiology 4. the appropriate diagnostic work up based on the presumed aetiology(RHEUMATOID ARTHRITIS)
Reading File
Finding Sources
Finding Sources
Searching PubMed
"rheumatoid arthritis"[MeSH Terms] AND "diagnosis"[MeSH Terms]
Finding Sources
Finding Sources
Searching PubMed
"rheumatoid arthritis" AND "classification criteria" AND "ACR EULAR"
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have comprehensive material from three major rheumatology textbooks. Let me compile the full, well-structured response.
Rheumatoid Arthritis: Differential Diagnosis & Diagnostic Workup
Part 1 - Differential Diagnosis (Broad)
Rheumatoid arthritis (RA) is a clinical diagnosis - no single finding or test is pathognomonic. A broad differential must be considered in any patient presenting with joint pain and swelling.
The major differential diagnoses are organized below by category:
Connective Tissue / Idiopathic Arthritis
| Condition | Key Distinguishing Features |
|---|---|
| Systemic Lupus Erythematosus (SLE) | Nonerosive arthritis; Jaccoud's arthropathy (reducible deformities); positive ANA, anti-dsDNA; ACPA negative; internal organ involvement (renal, pulmonary) |
| Spondyloarthropathy (PsA, AS, ReA) | Male predominance; often oligoarticular; large joint and lower extremity predominance; low back involvement; HLA-B27 positive; RF/ACPA negative; uveitis; associations with psoriasis or IBD |
| Adult-onset Still's Disease | Fever >39°C for >1 week; leukocytosis >10,000 with >80% PMNs; evanescent salmon-colored rash; sore throat; lymphadenopathy; splenomegaly; markedly elevated ferritin |
| Sjögren's Syndrome | Keratoconjunctivitis sicca (dry eyes), xerostomia (dry mouth); salivary gland enlargement; ANA positive (SS-A/SS-B); often RF positive but ACPA negative |
| Polymyalgia Rheumatica | Shoulder and hip girdle involvement (proximal); marked ESR/CRP elevation; RF/ACPA negative; association with giant cell arteritis; age >50 |
| Fibromyalgia | Widespread myalgia without true inflammatory arthritis; RF, ACPA, ESR, CRP all normal |
| RS3PE Syndrome | Synovial thickening + pitting edema of the hands; elderly men; RF/ACPA negative; exquisitely steroid-responsive; malignancy association |
| Sarcoidosis | Acute form: Löfgren's syndrome (erythema nodosum + hilar adenopathy); large joint predilection (ankle); often RF positive but ACPA negative; noncaseating granulomas on biopsy |
| Vasculitis | Seronegative polyarthritis with systemic symptoms; evidence of end-organ damage; markedly elevated ESR/CRP; ANCA may be positive |
| Palindromic Rheumatism | Episodic, self-limited attacks of joint swelling without persistent synovitis; may evolve into RA |
Infection-Related
| Condition | Key Distinguishing Features |
|---|---|
| Viral Arthritis (Parvovirus B19, Hep B/C, Rubella, EBV, Chikungunya) | Usually self-limited (<6 weeks); RF may be positive (especially Hep C); ACPA negative; travel history (Chikungunya); serology confirms |
| Bacterial Endocarditis | High fever; predominantly large joints; audible heart murmur; peripheral emboli; positive blood cultures; can be RF positive; ACPA negative |
| HIV | Brief acute joint pain at initial viremia; subsequent oligoarticular process; fever; positive HIV serology |
| Reactive Arthritis | Follows GI/GU infection; lower limb oligoarthritis; HLA-B27; "can't see, can't pee, can't bend the knee"; RF/ACPA negative |
| Septic Arthritis | Monoarticular; fever; markedly elevated WBC in joint fluid; urgent to exclude |
| Lyme Disease | Oligoarticular (especially knee); tick exposure history; Borrelia serology positive |
Crystal-Induced Arthritis
| Condition | Key Distinguishing Features |
|---|---|
| Gout (chronic tophaceous) | Tophi may resemble rheumatoid nodules; podagra (1st MTP); serum uric acid elevated; negatively birefringent crystals in synovial fluid; RF negative (ACPA negative) |
| Calcium Pyrophosphate Disease (CPPD) | Older patients; affects wrists, knees, MCPs; chondrocalcinosis on X-ray; weakly positive birefringent crystals; RF/ACPA negative |
Other
| Condition | Key Distinguishing Features |
|---|---|
| Osteoarthritis (erosive) | DIP joint predominance; Heberden's/Bouchard's nodes; no systemic features; RF/ACPA negative |
| Rheumatic Fever | Migratory polyarthritis following streptococcal infection; RF negative; subcutaneous nodules possible; carditis, chorea, erythema marginatum |
| Paraneoplastic Arthritis | Elderly; explosive onset; RF negative; consider in RS3PE pattern |
| Hypothyroidism | Causes rheumatic manifestations; commonly co-occurs with RA - TSH should be checked |
Part 2 - Clinical Features That Prioritize RA as the Aetiology
The following features, when present together, shift the differential strongly toward RA:
High-Probability Features for RA
- Symmetric small-joint polyarthritis - involving MCPs, PIPs, wrists, and MTPs
- Morning stiffness >1 hour - cardinal feature of inflammatory synovitis
- Age >18 years, more common in women (3:1 F:M ratio)
- Gradual, insidious onset over weeks to months (most common pattern, ~50% of cases); subacute or acute onset also occurs
- Positive RF and/or ACPA (anti-CCP) - positive in ~80% of RA patients; high-positive ACPA is highly specific for RA
- Elevated acute phase reactants (raised CRP and/or ESR)
- Symptoms persisting >6 weeks - distinguishes from most viral arthritides
- Rheumatoid nodules (present in ~20%) - subcutaneous, firm, over extensor surfaces
- Periarticular osteopenia and marginal erosions on X-ray
- Absence of features pointing to alternatives (no rash, no uveitis, no psoriasis, no tophi, no GI/GU precipitant)
A patient >18 years with symmetric joint pain and swelling in hands and feet + morning stiffness is very likely to have RA, especially if RF or ACPA is positive. - Rheumatology, 2-Volume Set (2022, Elsevier)
Part 3 - Applying the 2010 ACR/EULAR Classification Criteria
Used as a structured diagnostic support tool (score ≥6/10 = definite RA):
| Domain | Score |
|---|---|
| Joint involvement: 1 medium-large joint | 0 |
| 2-10 medium-large joints | 1 |
| 1-3 small joints | 2 |
| 4-10 small joints | 3 |
| >10 joints (at least 1 small) | 5 |
| Serology: Negative RF AND negative ACPA | 0 |
| Low-positive RF OR low-positive ACPA | 2 |
| High-positive RF OR high-positive ACPA | 3 |
| Acute phase reactants: Normal CRP AND ESR | 0 |
| Abnormal CRP OR ESR | 1 |
| Symptom duration: <6 weeks | 0 |
| ≥6 weeks | 1 |
Total: Score ≥6 = classified as RA
The 2010 criteria have sensitivity of 97% but lower specificity (55%) compared to the 1987 criteria (76%). They must be applied in patients with at least one joint showing synovitis not better explained by another disease. - Firestein & Kelley's Textbook of Rheumatology
Part 4 - Diagnostic Workup for Presumed RA
A. History and Physical Examination
- Full joint examination: document distribution, symmetry, swelling, tenderness, range of motion
- Assess for extra-articular features: nodules, eye involvement, serositis, skin changes
- Duration of symptoms, pattern of onset, morning stiffness duration
- Family history, comorbidities, drug history
- Travel history (to exclude Chikungunya, Lyme, etc.)
B. Serological Tests (Core)
| Test | Purpose |
|---|---|
| Rheumatoid Factor (RF) | Positive in ~70-80% of RA; also elevated in Hep C, SLE, Sjögren's, bacterial endocarditis - low specificity alone |
| Anti-CCP (ACPA) | More specific than RF (~95% specificity); may be positive years before disease onset; high-positive titre strongly supports RA |
| RF + ACPA combined | If both positive = seropositive RA, strongly supports diagnosis |
| ANA | To exclude SLE; positive in 15-30% of RA patients |
| Anti-dsDNA, Anti-Sm | If SLE suspected (helps differentiate) |
| Anti-SS-A / Anti-SS-B | If Sjögren's suspected |
| HLA-B27 | If spondyloarthropathy in differential |
C. Inflammatory Markers
| Test | Purpose |
|---|---|
| ESR | Elevated in active RA; reflects systemic inflammation; also useful for monitoring |
| CRP | More sensitive and rapidly responding to inflammation changes; useful for activity monitoring |
| Serum ferritin | Markedly elevated in Adult-onset Still's disease (can be >10,000 µg/L) |
| CBC with differential | Normocytic anaemia of chronic disease; thrombocytosis in active RA; leukocytosis suggests Still's or infection |
D. Metabolic and Organ-Function Tests
| Test | Purpose |
|---|---|
| LFTs, Renal function (eGFR) | Baseline before starting DMARDs (especially methotrexate) |
| Serum uric acid | To help exclude gout |
| TSH | Hypothyroidism: common co-occurrence with RA; shares rheumatic features |
| Blood cultures | If fever and monoarthritis - exclude septic arthritis and endocarditis |
| Hepatitis B and C serology | Hep C causes RF positivity + polyarthritis; Hep B reactivation risk with DMARDs; mandatory before biologic therapy |
| Tuberculosis screening (IGRA or Mantoux) | Mandatory before starting TNF-alpha inhibitors or other biologics |
E. Imaging
| Modality | Findings in RA |
|---|---|
| Plain X-rays (hands, wrists, feet) | Periarticular osteopenia, symmetric joint space narrowing, marginal erosions at "bare areas" of bone; first-line, baseline assessment |
| Musculoskeletal Ultrasound (MSUS) | Superior sensitivity over X-ray for early synovitis, tenosynovitis, early erosions; useful when physical exam equivocal |
| MRI (hands/wrists) | Most sensitive modality for early bone marrow oedema, early erosions, synovitis; used when diagnosis uncertain or disease activity monitoring |
| Chest X-ray | Baseline; detects pulmonary nodules, pleural effusion, interstitial lung disease |
| Note: New periarticular bone formation on imaging suggests alternative (OA, PsA, spondyloarthropathy, crystal disease) - not RA |
F. Synovial Fluid Analysis (if joint effusion present)
| Finding | Significance |
|---|---|
| WBC 5,000-50,000/mm³ (predominantly PMNs) | Inflammatory arthritis; non-specific for RA |
| Negatively birefringent crystals | Gout |
| Weakly positive birefringent crystals | CPPD |
| WBC >50,000 + positive culture | Septic arthritis - emergency |
| RF in synovial fluid | Low diagnostic value |
G. Synovial Biopsy
- Rarely needed for RA diagnosis
- Indicated if diagnosis remains unclear after full workup
- RA histology: villous hypertrophy, synovial lining hyperplasia, lymphocyte/plasma cell infiltration, pannus formation
Summary: Diagnostic Pathway at a Glance
Symmetric small joint polyarthritis + morning stiffness ≥1hr + duration ≥6 weeks
↓
Apply 2010 ACR/EULAR criteria (score ≥6 = RA)
↓
Labs: RF, ACPA (anti-CCP), CRP, ESR, CBC, LFTs, renal function, TSH, uric acid,
ANA ± ENA panel, Hep B/C serology, TB screening
↓
Imaging: X-rays hands/wrists/feet (baseline erosions, osteopenia)
± Ultrasound or MRI if equivocal
↓
Exclude key mimics: SLE (ANA, anti-dsDNA), viral arthritis (serology),
gout (uric acid, joint fluid), spondyloarthropathy (HLA-B27),
septic arthritis (blood/joint fluid cultures)
↓
Confirm RA → Initiate DMARD therapy within 3 months of symptom onset
Sources:
- Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set - p. 1502 (ACR/EULAR Criteria, Differential Diagnosis Table 72.2)
- Rheumatology, 2-Volume Set (2022, Elsevier) - p. 803 (Differential Diagnosis, Disease Onset, Diagnosis)
- Goldman-Cecil Medicine International Edition - Table 243-2 (Differential Diagnosis of RA)
- Lippincott Illustrated Reviews: Pharmacology - Clinical Application 40.1 (Diagnosis of RA)
This is a shared conversation. Sign in to Orris to start your own chat.